Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.
- 1 April 2007
- journal article
- clinical trial
- Published by American Psychological Association (APA) in Experimental and Clinical Psychopharmacology
- Vol. 15 (2) , 134-143
- https://doi.org/10.1037/1064-1297.15.2.134
Abstract
Naltrexone is a nonaddictive medication that blocks the euphoric effects of opioids. However, naltrexone treatment is associated with high rates of noncompliance and opioid relapse, possibly because it does not reduce stress and protracted withdrawal symptoms during early recovery. Prior clinical and preclinical research has indicated that both stress and drug-cue-related arousal response is associated with craving and vulnerability to relapse in a range of drug-using populations. To examine opioid craving and the subjective and cardiovascular response to stress and drug cues in naltrexone-treated opioid abusers. Eleven men and three women engaged in naltrexone treatment for opioid dependence. They were exposed to personalized stress, drug-cue, and neutral-relaxing imagery in a single laboratory session. Subjective (craving, emotion) and cardiovascular (heart rate, systolic blood pressure, and diastolic blood pressure) measures were assessed. Stress and drug-cue-related imagery significantly increased opioid craving, anxiety, and negative emotions and significantly decreased positive emotions compared to neutral imagery. Selective emotional responses were greater in the stress condition than in the drug-cue condition. Only stress-related imagery was associated with an increased cardiovascular response. Naltrexone-treated opioid abusers demonstrate vulnerability to stress and drug-cue-induced craving and arousal responses that may contribute to the high rates of noncompliance and relapse among opioid-dependent individuals undergoing naltrexone treatment. Pharmacological and behavioral interventions that specifically target the negative affectivity that co-occurs with drug-cue and stress-induced craving could be of benefit in improving naltrexone treatment outcomes in opioid dependence.Keywords
Funding Information
- National Institutes of Health (R01-DA18219; P50DA16556; K02-DA17232)
This publication has 45 references indexed in Scilit:
- Faculty Opinions recommendation of Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala.Published by H1 Connect ,2002
- Contingency management to enhance naltrexone treatment of opioid dependence: A randomized clinical trial of reinforcement magnitude.Experimental and Clinical Psychopharmacology, 2002
- How does stress increase risk of drug abuse and relapse?Psychopharmacology, 2001
- Repeated Lofexidine Treatment Attenuates Stress-Induced, But not Drug Cues-Induced Reinstatement of a Heroin-Cocaine Mixture (Speedball) Seeking in RatsNeuropsychopharmacology, 2001
- Lofexidine versus clonidine in rapid opiate detoxificationJournal of Substance Abuse Treatment, 2001
- The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-upSupportive Care in Cancer, 2001
- Heroin self-administration under a second-order schedule of reinforcement: acquisition and maintenance of heroin-seeking behaviour in rats.Psychopharmacology, 2000
- Psychological stress, drug-related cues and cocaine cravingPsychopharmacology, 2000
- Clonidine blocks stress‐induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neuronsEuropean Journal of Neuroscience, 2000
- Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration proceduresNeuropsychopharmacology, 1996